Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products Proceedings of a Workshop (2019) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 95-104
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 95... ...
Dr. Ameer is an associate editor of the Regenerative Engineering and Translational Medicine journa; a member of the boards of directors of the Biomedical Engineering Society (BMES)
|
From page 96... ...
Dr. Badylak is a fellow of the American Institute for Medical and Biological Engineering, a member of the Society for Biomaterials, a charter member of the Tissue Engineering Society International, a past president of the Tissue Engineering Regenerative Medicine International Society ( ERMIS)
|
From page 97... ...
Jennifer Elisseeff, Ph.D., is a professor in and the director of the Translational Tissue Engineering Center at the Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in chemical and biological engineering, materials science, and orthopedic surgery. She was elected a fellow of the American Institute of Medical and Biological Engineering, a member of the National Academy of Inventors, and a Young Global Leader by the World Economic Forum.
|
From page 98... ...
Dr. Fesnak is also a board-certified clinical pathologist and transfusion medicine physician who shares medical oversight of the blood bank, stem cell lab, and apheresis clinic.
|
From page 99... ...
Mr. Flanagan is currently on the boards of TrueVision Systems and the global advocacy organization Alliance for Regenerative Medicine, serves as a consultant to Leica MicroSystems, and recently sat on the board of Image Stream Medical until its 2017 acquisition by Olympus.
|
From page 100... ...
Dr. Muschler leads the Regenerative Medicine Laboratory at Cleveland Clinic, focusing on adult stem and progenitor cell biology and applications in quantitative clinical diagnostics, aging, gender variation, and tissue engineering.
|
From page 101... ...
Schulman is a research scientist with expertise in cardiovascular and renal molecular biology, stem cell culture techniques, and the design and implementation of stem cell preclinical studies and clinical trials for the treatment of cardiovascular disease, chronic kidney disease, and frailty. Her laboratory at ISCI focuses on identifying the mechanisms underlying the cardiovascular regenerative capacity of stem cells.
|
From page 102... ...
The facility he oversees develops and manufactures a wide range of cell and gene therapies for NIH intramural program phase I and II clinical trials. The staff in the cell processing section developed and is validating a good manufacturing process method to produce autologous induced pluripotent stem cells (iPSCs)
|
From page 103... ...
The other side of his research involves cutting-edge clinical trials. He was involved with one of the first growth factor treatments for Parkinson's disease and is currently working closely with neurosurgeons, neurologists, and other scientists to develop novel ways of using stem cells modified to release powerful growth factors to treat patients with neurological diseases, such as amyotrophic lateral s clerosis, Huntington's disease, Alzheimer's disease, and Parkinson's disease.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.